This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
I9_PULMOTHHD
pulmonary arterial hypertension: Pulmonary arterial hypertension (PAH) is a group of diseases characterized by elevated pulmonary arterial resistance leading to right heart failure. PAH is progressive and potentially fatal. PAH may be idiopathic and/ or familial, or induced by drug or toxin (drug-or toxin-induced PAH, see these terms) or associated with other diseases like congenital heart disease, connective tissue disease, HIV, schistosomiasis, portal hypertension (PAH associated with other disease, see this term).
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
429209 |
1. Apply sex-specific ruleNone |
429209 |
2. Check conditionsNone |
429209 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1356 |
4. Check minimum number of eventsNone |
1356 |
5. Include endpoints |
1356 |
6. Filter based on genotype QC (FinnGen only) |
1313 |
Control definitions (FinnGen only)
Extra metadata
List of similar endpoints to Other pulmonary heart/vessel disease based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
All | Female | Male | |
---|---|---|---|
Number of individuals | 1313 | 573 | 740 |
Unadjusted period prevalence (%) | 0.34 | 0.25 | 0.41 |
Median age at first event (years) | 69.92 | 68.09 | 71.34 |
Not a core endpoint, no data to show.
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Index endpoint: I9_PULMOTHHD – Other pulmonary heart/vessel disease
GWS hits: -
Loading Relationships table